Test Code COL7 Anti-Collagen type VII, IgG Antibodies, Serum
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 2 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Secondary ID
616879Useful For
Initial screening test in the diagnosis of epidermolysis bullosa acquisita and other immunobullous diseases mediated by collagen VII
Method Name
Enzyme-Linked Immunosorbent Assay (ELISA)
Reporting Name
Anti-Collagen type VII, SerumSpecimen Type
SerumSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 30 days | ||
Ambient | 14 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Clinical Information
Epidermolysis bullosa acquisita and certain other rare immunobullous diseases, including bullous lupus erythematosus, are caused by the development of IgG antibodies directed against collagen type VII, which lead to blisters and erosions that may heal with scarring. Circulating IgG autoantibodies against collagen type VII can be found in patient serum in these conditions.
Reference Values
Collagen type VII
<20 RU/mL (negative)
≥20 RU/mL (positive)
Interpretation
Antibodies to IgG collagen type VII have been shown to be present in patients with epidermolysis bullosa acquisita and certain other rare immunobullous diseases, including bullous lupus erythematosus
CPT Code Information
83516
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
COL7 | Anti-Collagen type VII, Serum | In Process |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
616879 | COL7, S | 94096-5 |